Pharmaceutical manufacturing capacities in the post-pandemic era: sustainable industrial policies and practices
Dayama, A . and Patil, R. (2022). Pharmaceutical manufacturing capacities in the post-pandemic era: sustainable industrial policies and practices. IISc-CSP, Bangalore. 02C/01/2022. https://csp.iisc.ac.in/02C-01-2022. pp. 01-04
As the COVID-19 pandemic diffuses beyond borders, national governments are on mission mode to support stretched health systems and implement redistributive policies. As all of us are facing this hard-hitting planetary disaster, we must address it collectively. However, the nationalism wave is soaring globally. The pandemic emerged as the biggest crisis humanity has ever faced after the World Wars. We need to anticipate and address its after-effects carefully. Now, would we care to step together for post-pandemic recovery? Though the nature of the world after the pandemic remains to be fully understood, we explore the policy options that we can latch on to through the pandemic lessons.
Reverse pharmacology for Ayurveda-based modern medicines
Dayama, A. and Patil, R. (2022). Reverse pharmacology for Ayurveda-based modern medicines. IISc-CSP, Bangalore. 01C/01/2022. https://csp.iisc.ac.in/01C-01-2022. pp. 01-05
Traditional medicines emerged as a boon for the populations with strong socio-cultural and historical influences or in the absence of alternative or complementary therapies. Ayurveda, an Indian system of medicine, built remarkable knowledge over the practice of several thousands of years. This gold mine of clinical observations is attracting global pharmaceutical corporations to fuel their investigational drug pipelines. What’s good in this for the modern medicines, the system of Ayurveda, and public health? Let’s find out.